logo

Slide Shows

Share
Events

New Drugs Approved In January The process of drug development is challenging. Some drugs pass the FDA muster easily, while some face a host of hurdles before getting the official stamp of approval.

Central Bank Decisions In January Several central banks chose to leave interest rates unchanged at the start of 2020, while a few opted for a cut. Some central banks including the Federal Reserve voiced concern over the novel coronavirus outbreak in China and its expected adverse impact on the economy. Here is a look at some of the central bank decisions of January.

China Coronavirus Scare The term public health emergency of international concern implies “a situation that is serious, unusual or unexpected; carries implications for public health beyond the affected State’s national border, and may require immediate international action”.

Bank of England Set To Keep Rates Unchanged The Bank of England is set to keep its monetary policy rates and monetary stimulus unchanged on January 30, Thursday, after economic data signaled development of positive momentum following the general election late last year and as political uncertainty linked to Brexit eased. This will also be the last rate-setting session chaired by Governor Mark Carney, who is set to leave his post mid-March for his new job at the UN.

Biotech Stocks Facing FDA Decision In February 2020 February is just around the corner. It’s that time to take a look back at some of the top news stories of January and look ahead at what's coming next over the horizon on the regulatory front.

Lagarde Unveils ECB Strategy Review European Central Bank President Christine Lagarde launched a broad review of the bank's monetary policy strategy on January 23 that will cover a host of issues ranging from the inflation target to the impact of climate change. This is the first such exercise in 17 years. The process is undertaken at a time when questions are being raised about the effectiveness of the ECB's price stability mandate. The review is expected to conclude by the end of this year.

IMF Cuts Global Growth Forecast On India Slowdown The International Monetary Fund cut the global growth forecasts for this year and next, on January 23, citing mainly the weaker-than-expected expansion in India. While there are early signs of stabilization in the global economy, there was no room for complacency, the lender cautioned.

New Drugs Approved In December The process of drug development is challenging. Some drugs pass the FDA muster easily, while some face a host of hurdles before getting the official stamp of approval.

Ten best companies to work for in US LinkedIn’s ‘2019 LinkedIn Top Companies’ list reveals the top 50 companies in the U.S. that are the most sought after by prospective employees in search of fulfilling careers. LinkedIn is a social network for professionals. The list identifies the companies where LinkedIn’s more than 610 million global members most want to work. This is LinkedIn’s fourth annual ranking of the most sought-after companies today. LinkedIn parses activity by its members to uncover the companies that are attracting the most attention from job-seekers and then striving to retain that talent.

China 2019 Growth Weakest In Nearly Three Decades China's GDP growth slowed sharply to its weakest level in 29 years in 2019, as the economy struggled with subdued demand both at home and abroad amid the trade spat with the United States. The government had announced several stimulus packages for different sectors to cushion the impact of the slowdown. Official data also revealed that the country's birth rate dropped to a record low in 2019.

>